Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Plugging One VC Gap

This article was originally published in Start Up

Executive Summary

Two years ago, the UK's publicly-funded Medical Research Council set up a new venture fund with a right of first refusal to all MRC-funded technology. Its British VC competitors greeted the newcomer, which claimed to want to fill a gap in seed-stage investing, coolly--they felt that no such gap existed and that UK Medical Ventures Fund would have an unfair advantage. Whether they're still jealous is uncertain, but they are doing deals with the new fund, which has significantly stepped up the rate at which MRC technology is transferred to the marketplace.
Advertisement

Related Content

The IP Land Grab: New UK Tech Transfer Models
The IP Land Grab: New UK Tech Transfer Models
Medical Research Council Technology

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC090291

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel